“Time to Onset of a Minimal Clinically Important Difference in DLQI with Guselkumab Treatment in VOYAGE 1” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s236. doi:10.25251/skin.7.supp.236.